Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

AHA-1 Inhibitors

AHA-1 inhibitors belong to a distinctive chemical class renowned for their specific targeting of the Adenosine triphosphate (ATP)-dependent protease ClpXP system. The acronym AHAstands for ATPase associated with various cellular activities, and AHA-1 denotes a class of molecules that modulate the activity of these ATPases, specifically those associated with ClpXP. The ClpXP system is a crucial cellular protease responsible for the degradation of misfolded or damaged proteins, playing a pivotal role in maintaining cellular protein quality control. AHA-1 inhibitors exert their influence by interacting with the AHA-1 co-chaperone protein, a key component in the ClpXP machinery. AHA-1 inhibitors exhibit a diverse array of chemical scaffolds, showcasing the versatility in their design and synthesis. Researchers have identified and characterized various compounds falling within the AHA-1 inhibitor class, each displaying unique binding affinities and potencies against the AHA-1 protein. These inhibitors disrupt the normal functioning of the ClpXP system by impeding the interaction between AHA-1 and its ATPase target, thereby affecting the proteolytic capabilities of the ClpXP complex.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$39.00
$59.00
$104.00
$206.00
8
(1)

Geldanamycin binds to the ATP-binding pocket of Hsp90, thereby inhibiting its ATPase activity and consequently, the activation of AHA1.

17-AAG

75747-14-7sc-200641
sc-200641A
1 mg
5 mg
$67.00
$156.00
16
(2)

17-AAG, an analogue of Geldanamycin, also inhibits Hsp90s ATPase activity, indirectly inhibiting AHA1.

17-DMAG

467214-20-6sc-202005
1 mg
$205.00
8
(1)

17-DMAG, another Geldanamycin derivative, binds to Hsp90, thereby inhibiting Hsp90 ATPase activity and in turn, AHA1.

Radicicol

12772-57-5sc-200620
sc-200620A
1 mg
5 mg
$92.00
$333.00
13
(1)

Radicicol binds to the ATP pocket of Hsp90, hence inhibiting its ATPase activity which indirectly affects AHA1.

NVP-AUY922

747412-49-3sc-364551
sc-364551A
sc-364551B
sc-364551C
sc-364551D
sc-364551E
5 mg
25 mg
100 mg
250 mg
1 g
5 g
$150.00
$263.00
$726.00
$1400.00
$2900.00
$11000.00
3
(1)

NVP-AUY922 is a non-geldanamycin Hsp90 inhibitor that can indirectly inhibit AHA1.

Ganetespib

888216-25-9sc-364496
sc-364496A
10 mg
250 mg
$273.00
$1040.00
(0)

STA-9090 is a synthetic small molecule inhibitor of Hsp90, thus indirectly inhibiting AHA1.

BIIB 021

848695-25-0sc-364434
sc-364434A
5 mg
25 mg
$128.00
$650.00
(0)

BIIB021 is a synthetic inhibitor of Hsp90, thereby indirectly inhibiting AHA1.

AT13387

912999-49-6sc-364415
sc-364415A
10 mg
50 mg
$555.00
$1606.00
(0)

AT13387 is a non-geldanamycin Hsp90 inhibitor that can indirectly inhibit AHA1.

Debio 0932

1061318-81-7sc-507516
10 mg
$280.00
(0)

Debio-0932 is a second-generation oral Hsp90 inhibitor that can indirectly inhibit AHA1.